Search

everythinglearnresearchcommunity

for

Search:↓

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Laser treatment, especially when combined with other therapies, is effective for hair regrowth in alopecia areata.

Early diagnosis and treatment of nail lichen planus in children can prevent permanent nail damage.

A woman with lupus experienced hair regrowth after treatment, but hair transplantation is not advised for her condition.

The multi-injection plate is a less painful and more efficient method for treating patchy hair loss.

Fractional CO2 laser is more effective and safer than steroid injections for treating alopecia areata.

Corticosteroid injections helped eyebrow hair regrow in men with alopecia areata.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Some treatments can help with hair regrowth in alopecia areata, but results vary and long-term use is often needed without changing the disease's outcome.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Steroids are the best treatment for Alopecia Areata with few side effects.

Different treatments for alopecia areata have unpredictable results and varying success rates.

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

The girl with autoimmune hair loss might regrow hair within a year, and treatments can help but not prevent recurrence; dermatologist referral and corticosteroids are recommended.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

The document concludes that various skin conditions have specific treatments and that adequate calcium intake may prevent osteoporosis.

Using methods like lasers and microneedling with drugs can improve hair regrowth for alopecia, but more research is needed on safety and best practices.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

Lichen planopilaris can be triggered by prolonged scalp traction and can be treated with corticosteroids.

Keloid scars can form after hair transplant surgery and should be prevented and treated early.

Alopecia areata causes sudden hair loss, often resolves within a year, but can recur.

Alopecia areata causes significant emotional distress, including high rates of depression and anxiety.

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.